The giant Swiss pharmaceutical industry is planning to invest $ 50 billion (43 billion euros) in the United States over the next five years, it said today. These investments are expected to allow Roche to enhance its potential in drug production and its diagnosis activities, the group said in a statement. They are going to serve to expand the possibilities to many facilities in the group, mainly in Kentucky, Indiana, New Jersey, Oregon and California, while Roche clarifies that she plans to make announcements about an additional installation soon. The group, first in the world in Oncology, already has 13 US factories and 15 research and development facilities and employs 25,000 employees there. Roche’s Swiss competitor, Novartis, announced ten days ago that it intends to invest $ 23 billion in the United States over a five -year period. Source: RES
Source: News Beast
With 6 years of experience, I bring to the table captivating and informative writing in the world news category. My expertise covers a range of industries, including tourism, technology, forex and stocks. From brief social media posts to in-depth articles, I am dedicated to creating compelling content for various platforms.
